KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Asset Utilization Ratio: 2012-2025

Historic Asset Utilization Ratio for Travere Therapeutics (TVTX) over the last 11 years, with Sep 2025 value amounting to 0.80.

  • Travere Therapeutics' Asset Utilization Ratio rose 106.71% to 0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.80, marking a year-over-year increase of 106.71%. This contributed to the annual value of 0.34 for FY2024, which is 69.65% up from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Asset Utilization Ratio is 0.80, which was up 31.76% from 0.60 recorded in Q2 2025.
  • In the past 5 years, Travere Therapeutics' Asset Utilization Ratio registered a high of 0.80 during Q3 2025, and its lowest value of 0.12 during Q3 2022.
  • For the 3-year period, Travere Therapeutics' Asset Utilization Ratio averaged around 0.35, with its median value being 0.29 (2024).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 55.24% in 2022, then spiked by 137.01% in 2024.
  • Quarterly analysis of 5 years shows Travere Therapeutics' Asset Utilization Ratio stood at 0.22 in 2021, then dropped by 28.16% to 0.16 in 2022, then climbed by 14.44% to 0.18 in 2023, then soared by 137.01% to 0.42 in 2024, then skyrocketed by 106.71% to 0.80 in 2025.
  • Its Asset Utilization Ratio stands at 0.80 for Q3 2025, versus 0.60 for Q2 2025 and 0.48 for Q1 2025.